Trial Profile
A Phase 2a Study To Investigate The Effects Of AER 002 On Mucociliary Clearance In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs AER 002 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Aug 2019 Status changed from recruiting to completed.
- 20 May 2011 New trial record